Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
Bioconjug Chem ; 32(8): 1834-1844, 2021 08 18.
Artículo en Inglés | MEDLINE | ID: mdl-34369158

RESUMEN

Antibody-drug conjugates have become one of the most actively developed classes of drugs in recent years. Their great potential comes from combining the strengths of large and small molecule therapeutics: the exquisite specificity of antibodies and the highly potent nature of cytotoxic compounds. More recently, the approach of engineering antibody-drug conjugate scaffolds to achieve highly controlled drug to antibody ratios has focused on substituting or inserting cysteines to facilitate site-specific conjugation. Herein, we characterize an antibody scaffold engineered with an inserted cysteine that formed an unexpected disulfide bridge during manufacture. A combination of mass spectrometry and biophysical techniques have been used to understand how the additional disulfide bridge forms, interconverts, and changes the stability and structural dynamics of the antibody intermediate. This quantitative and structurally resolved model of the local and global changes in structure and dynamics associated with the engineering and subsequent disulfide-bonded variant can assist future engineering strategies.


Asunto(s)
Especificidad de Anticuerpos , Antineoplásicos/química , Inmunoconjugados , Compuestos de Sulfhidrilo/química , Anticuerpos Monoclonales , Sitios de Unión , Diseño de Fármacos , Modelos Moleculares , Conformación Proteica
2.
Angew Chem Int Ed Engl ; 54(50): 15156-9, 2015 Dec 07.
Artículo en Inglés | MEDLINE | ID: mdl-26482340

RESUMEN

Immunoglobulin G (IgG) monoclonal antibodies (mAbs) are a major class of medicines, with high specificity and affinity towards targets spanning many disease areas. The antibody Fc (fragment crystallizable) region is a vital component of existing antibody therapeutics, as well as many next generation biologic medicines. Thermodynamic stability is a critical property for the development of stable and effective therapeutic proteins. Herein, a combination of ion-mobility mass spectrometry (IM-MS) and hydrogen/deuterium exchange mass spectrometry (HDX-MS) approaches have been used to inform on the global and local conformation and dynamics of engineered IgG Fc variants with reduced thermodynamic stability. The changes in conformation and dynamics have been correlated with their thermodynamic stability to better understand the destabilising effect of functional IgG Fc mutations and to inform engineering of future therapeutic proteins.


Asunto(s)
Anticuerpos Monoclonales/química , Inmunoglobulina G/química , Termodinámica , Medición de Intercambio de Deuterio , Humanos , Espectrometría de Masas , Conformación Proteica
3.
J Med Chem ; 67(12): 10436-10446, 2024 Jun 27.
Artículo en Inglés | MEDLINE | ID: mdl-38783480

RESUMEN

Ion mobility mass spectrometry (IM-MS) can be used to analyze native proteins according to their size and shape. By sampling individual molecules, it allows us to study mixtures of conformations, as long as they have different collision cross sections and maintain their native conformation after dehydration and vaporization in the mass spectrometer. Even though conformational heterogeneity of prolyl oligopeptidase has been demonstrated in solution, it is not detectable in IM-MS. Factors that affect the conformation in solution, binding of an active site ligand, the stabilizing Ser554Ala mutation, and acidification do not qualitatively affect the collision-induced unfolding pattern. However, measuring the protection of accessible cysteines upon ligand binding provides a principle for the development of MS-based ligand screening methods.


Asunto(s)
Prolil Oligopeptidasas , Conformación Proteica , Serina Endopeptidasas , Prolil Oligopeptidasas/metabolismo , Serina Endopeptidasas/química , Serina Endopeptidasas/metabolismo , Ligandos , Espectrometría de Movilidad Iónica , Modelos Moleculares , Espectrometría de Masas/métodos , Dominio Catalítico , Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA